MBX Biosciences, Inc. (MBX) income statement
MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$49.55−3.86 (-7.23%)
Close on Nov 20, 2026Market cap $2.39BP/E –Yield –
MBX Biosciences, Inc. financial ratios
See a number that looks wrong?